nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—PLA2G4A—Orlistat—type 2 diabetes mellitus	0.353	0.696	CbGbCtD
Epirubicin—UGT2B7—Losartan—type 2 diabetes mellitus	0.0868	0.171	CbGbCtD
Epirubicin—ABCC1—Glyburide—type 2 diabetes mellitus	0.0674	0.133	CbGbCtD
Epirubicin—CHD1—retina—type 2 diabetes mellitus	0.00347	0.0592	CbGeAlD
Epirubicin—CHD1—nephron tubule—type 2 diabetes mellitus	0.00326	0.0558	CbGeAlD
Epirubicin—CHD1—pancreas—type 2 diabetes mellitus	0.00285	0.0487	CbGeAlD
Epirubicin—CHD1—cortex of kidney—type 2 diabetes mellitus	0.00279	0.0477	CbGeAlD
Epirubicin—DHCR7—islet of Langerhans—type 2 diabetes mellitus	0.00273	0.0467	CbGeAlD
Epirubicin—CHD1—adipose tissue—type 2 diabetes mellitus	0.00259	0.0442	CbGeAlD
Epirubicin—YWHAG—islet of Langerhans—type 2 diabetes mellitus	0.00251	0.0429	CbGeAlD
Epirubicin—DHCR7—retina—type 2 diabetes mellitus	0.00234	0.0399	CbGeAlD
Epirubicin—AURKA—kidney—type 2 diabetes mellitus	0.00231	0.0395	CbGeAlD
Epirubicin—DHCR7—nephron tubule—type 2 diabetes mellitus	0.0022	0.0376	CbGeAlD
Epirubicin—YWHAG—retina—type 2 diabetes mellitus	0.00214	0.0366	CbGeAlD
Epirubicin—DHCR7—pancreas—type 2 diabetes mellitus	0.00192	0.0328	CbGeAlD
Epirubicin—DHCR7—cortex of kidney—type 2 diabetes mellitus	0.00188	0.0322	CbGeAlD
Epirubicin—YWHAG—cardiovascular system—type 2 diabetes mellitus	0.00181	0.031	CbGeAlD
Epirubicin—CHD1—liver—type 2 diabetes mellitus	0.00181	0.031	CbGeAlD
Epirubicin—YWHAG—kidney—type 2 diabetes mellitus	0.00177	0.0303	CbGeAlD
Epirubicin—YWHAG—pancreas—type 2 diabetes mellitus	0.00176	0.0301	CbGeAlD
Epirubicin—DHCR7—adipose tissue—type 2 diabetes mellitus	0.00174	0.0298	CbGeAlD
Epirubicin—YWHAG—cortex of kidney—type 2 diabetes mellitus	0.00173	0.0295	CbGeAlD
Epirubicin—UGT2B7—kidney—type 2 diabetes mellitus	0.0016	0.0274	CbGeAlD
Epirubicin—YWHAG—adipose tissue—type 2 diabetes mellitus	0.0016	0.0273	CbGeAlD
Epirubicin—Doxorubicin—NOS1—type 2 diabetes mellitus	0.00154	0.288	CrCbGaD
Epirubicin—AURKA—liver—type 2 diabetes mellitus	0.00146	0.025	CbGeAlD
Epirubicin—PLA2G4A—cardiovascular system—type 2 diabetes mellitus	0.00135	0.0231	CbGeAlD
Epirubicin—PLA2G4A—cortex of kidney—type 2 diabetes mellitus	0.00129	0.022	CbGeAlD
Epirubicin—DHCR7—liver—type 2 diabetes mellitus	0.00122	0.0209	CbGeAlD
Epirubicin—PLA2G4A—adipose tissue—type 2 diabetes mellitus	0.00119	0.0204	CbGeAlD
Epirubicin—TOP2A—adipose tissue—type 2 diabetes mellitus	0.00113	0.0194	CbGeAlD
Epirubicin—YWHAG—liver—type 2 diabetes mellitus	0.00112	0.0192	CbGeAlD
Epirubicin—UGT2B7—liver—type 2 diabetes mellitus	0.00101	0.0173	CbGeAlD
Epirubicin—Doxorubicin—NOS3—type 2 diabetes mellitus	0.000837	0.156	CrCbGaD
Epirubicin—Doxorubicin—NOS2—type 2 diabetes mellitus	0.000809	0.151	CrCbGaD
Epirubicin—PLA2G4A—Glyburide—Glimepiride—type 2 diabetes mellitus	0.000747	0.141	CbGdCrCtD
Epirubicin—PLA2G4A—Glyburide—Tolazamide—type 2 diabetes mellitus	0.000747	0.141	CbGdCrCtD
Epirubicin—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000737	0.0126	CbGeAlD
Epirubicin—PLA2G4A—Glyburide—Gliclazide—type 2 diabetes mellitus	0.000708	0.134	CbGdCrCtD
Epirubicin—PLA2G4A—Glyburide—Glipizide—type 2 diabetes mellitus	0.000708	0.134	CbGdCrCtD
Epirubicin—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000682	0.0117	CbGeAlD
Epirubicin—Daunorubicin—ABCC2—type 2 diabetes mellitus	0.000661	0.123	CrCbGaD
Epirubicin—PLA2G4A—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.000648	0.122	CbGdCrCtD
Epirubicin—Doxorubicin—ABCC2—type 2 diabetes mellitus	0.000536	0.1	CrCbGaD
Epirubicin—PLA2G4A—Enalapril—Nateglinide—type 2 diabetes mellitus	0.000516	0.0974	CbGdCrCtD
Epirubicin—ABCC1—liver—type 2 diabetes mellitus	0.000479	0.00818	CbGeAlD
Epirubicin—Daunorubicin—CYP1A2—type 2 diabetes mellitus	0.000441	0.0824	CrCbGaD
Epirubicin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.000384	0.0725	CbGdCrCtD
Epirubicin—AURKA—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000383	0.0723	CbGdCrCtD
Epirubicin—PLA2G4A—Enalapril—Ramipril—type 2 diabetes mellitus	0.000314	0.0592	CbGdCrCtD
Epirubicin—Daunorubicin—CYP3A4—type 2 diabetes mellitus	0.000292	0.0546	CrCbGaD
Epirubicin—Doxorubicin—CYP3A4—type 2 diabetes mellitus	0.000237	0.0443	CrCbGaD
Epirubicin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000146	0.0276	CbGdCrCtD
Epirubicin—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.65e-05	0.000278	CcSEcCtD
Epirubicin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.64e-05	0.000277	CcSEcCtD
Epirubicin—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.64e-05	0.000277	CcSEcCtD
Epirubicin—Vertigo—Losartan—type 2 diabetes mellitus	7.63e-05	0.000277	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000277	CcSEcCtD
Epirubicin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.000277	CcSEcCtD
Epirubicin—Somnolence—Valsartan—type 2 diabetes mellitus	7.62e-05	0.000277	CcSEcCtD
Epirubicin—Syncope—Losartan—type 2 diabetes mellitus	7.62e-05	0.000277	CcSEcCtD
Epirubicin—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.61e-05	0.000276	CcSEcCtD
Epirubicin—Leukopenia—Losartan—type 2 diabetes mellitus	7.6e-05	0.000276	CcSEcCtD
Epirubicin—Discomfort—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000276	CcSEcCtD
Epirubicin—Skin disorder—Metformin—type 2 diabetes mellitus	7.58e-05	0.000275	CcSEcCtD
Epirubicin—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000274	CcSEcCtD
Epirubicin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.55e-05	0.000274	CcSEcCtD
Epirubicin—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000274	CcSEcCtD
Epirubicin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000274	CcSEcCtD
Epirubicin—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.52e-05	0.000273	CcSEcCtD
Epirubicin—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000273	CcSEcCtD
Epirubicin—Palpitations—Losartan—type 2 diabetes mellitus	7.51e-05	0.000272	CcSEcCtD
Epirubicin—Nausea—Glimepiride—type 2 diabetes mellitus	7.48e-05	0.000272	CcSEcCtD
Epirubicin—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000271	CcSEcCtD
Epirubicin—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.47e-05	0.000271	CcSEcCtD
Epirubicin—Nausea—Sitagliptin—type 2 diabetes mellitus	7.46e-05	0.000271	CcSEcCtD
Epirubicin—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.46e-05	0.000271	CcSEcCtD
Epirubicin—Asthenia—Glyburide—type 2 diabetes mellitus	7.45e-05	0.000271	CcSEcCtD
Epirubicin—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.45e-05	0.00027	CcSEcCtD
Epirubicin—Anorexia—Metformin—type 2 diabetes mellitus	7.44e-05	0.00027	CcSEcCtD
Epirubicin—Cough—Losartan—type 2 diabetes mellitus	7.41e-05	0.000269	CcSEcCtD
Epirubicin—Urticaria—Gliclazide—type 2 diabetes mellitus	7.41e-05	0.000269	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000269	CcSEcCtD
Epirubicin—Alopecia—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000268	CcSEcCtD
Epirubicin—Fatigue—Valsartan—type 2 diabetes mellitus	7.39e-05	0.000268	CcSEcCtD
Epirubicin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.37e-05	0.000268	CcSEcCtD
Epirubicin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.37e-05	0.000268	CcSEcCtD
Epirubicin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000267	CcSEcCtD
Epirubicin—Oedema—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000267	CcSEcCtD
Epirubicin—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.36e-05	0.000267	CcSEcCtD
Epirubicin—Pruritus—Glyburide—type 2 diabetes mellitus	7.35e-05	0.000267	CcSEcCtD
Epirubicin—Mental disorder—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000266	CcSEcCtD
Epirubicin—Constipation—Valsartan—type 2 diabetes mellitus	7.33e-05	0.000266	CcSEcCtD
Epirubicin—Infection—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000266	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000265	CcSEcCtD
Epirubicin—Fatigue—Orlistat—type 2 diabetes mellitus	7.3e-05	0.000265	CcSEcCtD
Epirubicin—Hypotension—Metformin—type 2 diabetes mellitus	7.29e-05	0.000265	CcSEcCtD
Epirubicin—Erythema—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000264	CcSEcCtD
Epirubicin—Malnutrition—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000264	CcSEcCtD
Epirubicin—Shock—Irbesartan—type 2 diabetes mellitus	7.25e-05	0.000263	CcSEcCtD
Epirubicin—Pain—Orlistat—type 2 diabetes mellitus	7.24e-05	0.000263	CcSEcCtD
Epirubicin—Chest pain—Losartan—type 2 diabetes mellitus	7.23e-05	0.000263	CcSEcCtD
Epirubicin—Arthralgia—Losartan—type 2 diabetes mellitus	7.23e-05	0.000263	CcSEcCtD
Epirubicin—Myalgia—Losartan—type 2 diabetes mellitus	7.23e-05	0.000263	CcSEcCtD
Epirubicin—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.23e-05	0.000262	CcSEcCtD
Epirubicin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000262	CcSEcCtD
Epirubicin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000262	CcSEcCtD
Epirubicin—Anxiety—Losartan—type 2 diabetes mellitus	7.21e-05	0.000262	CcSEcCtD
Epirubicin—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.000261	CcSEcCtD
Epirubicin—Rash—Bromocriptine—type 2 diabetes mellitus	7.17e-05	0.00026	CcSEcCtD
Epirubicin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.16e-05	0.00026	CcSEcCtD
Epirubicin—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.00026	CcSEcCtD
Epirubicin—Tension—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000259	CcSEcCtD
Epirubicin—Discomfort—Losartan—type 2 diabetes mellitus	7.14e-05	0.000259	CcSEcCtD
Epirubicin—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000259	CcSEcCtD
Epirubicin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000259	CcSEcCtD
Epirubicin—Headache—Bromocriptine—type 2 diabetes mellitus	7.12e-05	0.000258	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.11e-05	0.000258	CcSEcCtD
Epirubicin—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.11e-05	0.000258	CcSEcCtD
Epirubicin—Nervousness—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000257	CcSEcCtD
Epirubicin—Dry mouth—Losartan—type 2 diabetes mellitus	7.07e-05	0.000257	CcSEcCtD
Epirubicin—Anorexia—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000255	CcSEcCtD
Epirubicin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.01e-05	0.000254	CcSEcCtD
Epirubicin—Paraesthesia—Metformin—type 2 diabetes mellitus	7.01e-05	0.000254	CcSEcCtD
Epirubicin—Muscle spasms—Ramipril—type 2 diabetes mellitus	7e-05	0.000254	CcSEcCtD
Epirubicin—Confusional state—Losartan—type 2 diabetes mellitus	6.99e-05	0.000254	CcSEcCtD
Epirubicin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.98e-05	0.000253	CcSEcCtD
Epirubicin—Dyspnoea—Metformin—type 2 diabetes mellitus	6.96e-05	0.000253	CcSEcCtD
Epirubicin—Somnolence—Metformin—type 2 diabetes mellitus	6.94e-05	0.000252	CcSEcCtD
Epirubicin—Oedema—Losartan—type 2 diabetes mellitus	6.93e-05	0.000252	CcSEcCtD
Epirubicin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.93e-05	0.000252	CcSEcCtD
Epirubicin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.93e-05	0.000251	CcSEcCtD
Epirubicin—Infection—Losartan—type 2 diabetes mellitus	6.89e-05	0.00025	CcSEcCtD
Epirubicin—Hypotension—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.00025	CcSEcCtD
Epirubicin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.00025	CcSEcCtD
Epirubicin—Dyspepsia—Metformin—type 2 diabetes mellitus	6.87e-05	0.000249	CcSEcCtD
Epirubicin—Shock—Losartan—type 2 diabetes mellitus	6.82e-05	0.000248	CcSEcCtD
Epirubicin—Urticaria—Valsartan—type 2 diabetes mellitus	6.81e-05	0.000247	CcSEcCtD
Epirubicin—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.8e-05	0.000247	CcSEcCtD
Epirubicin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.79e-05	0.000246	CcSEcCtD
Epirubicin—Decreased appetite—Metformin—type 2 diabetes mellitus	6.79e-05	0.000246	CcSEcCtD
Epirubicin—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.78e-05	0.000246	CcSEcCtD
Epirubicin—Tachycardia—Losartan—type 2 diabetes mellitus	6.77e-05	0.000246	CcSEcCtD
Epirubicin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000245	CcSEcCtD
Epirubicin—Nausea—Bromocriptine—type 2 diabetes mellitus	6.75e-05	0.000245	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.74e-05	0.000245	CcSEcCtD
Epirubicin—Fatigue—Metformin—type 2 diabetes mellitus	6.73e-05	0.000244	CcSEcCtD
Epirubicin—Urticaria—Orlistat—type 2 diabetes mellitus	6.73e-05	0.000244	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000244	CcSEcCtD
Epirubicin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.7e-05	0.000243	CcSEcCtD
Epirubicin—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000243	CcSEcCtD
Epirubicin—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000243	CcSEcCtD
Epirubicin—Asthenia—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.000243	CcSEcCtD
Epirubicin—Agitation—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000243	CcSEcCtD
Epirubicin—Constipation—Metformin—type 2 diabetes mellitus	6.67e-05	0.000242	CcSEcCtD
Epirubicin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.61e-05	0.00024	CcSEcCtD
Epirubicin—Anorexia—Losartan—type 2 diabetes mellitus	6.61e-05	0.00024	CcSEcCtD
Epirubicin—Vomiting—Glyburide—type 2 diabetes mellitus	6.61e-05	0.00024	CcSEcCtD
Epirubicin—Pruritus—Gliclazide—type 2 diabetes mellitus	6.6e-05	0.00024	CcSEcCtD
Epirubicin—Malaise—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000238	CcSEcCtD
Epirubicin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000238	CcSEcCtD
Epirubicin—Rash—Glyburide—type 2 diabetes mellitus	6.55e-05	0.000238	CcSEcCtD
Epirubicin—Somnolence—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000238	CcSEcCtD
Epirubicin—Dermatitis—Glyburide—type 2 diabetes mellitus	6.54e-05	0.000238	CcSEcCtD
Epirubicin—Vertigo—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000238	CcSEcCtD
Epirubicin—Syncope—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000237	CcSEcCtD
Epirubicin—Leukopenia—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000237	CcSEcCtD
Epirubicin—Headache—Glyburide—type 2 diabetes mellitus	6.51e-05	0.000236	CcSEcCtD
Epirubicin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000235	CcSEcCtD
Epirubicin—Hypotension—Losartan—type 2 diabetes mellitus	6.48e-05	0.000235	CcSEcCtD
Epirubicin—Palpitations—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000234	CcSEcCtD
Epirubicin—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.43e-05	0.000233	CcSEcCtD
Epirubicin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.000232	CcSEcCtD
Epirubicin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000232	CcSEcCtD
Epirubicin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.38e-05	0.000232	CcSEcCtD
Epirubicin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.38e-05	0.000232	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000231	CcSEcCtD
Epirubicin—Cough—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000231	CcSEcCtD
Epirubicin—Fatigue—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000231	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.32e-05	0.000229	CcSEcCtD
Epirubicin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.32e-05	0.000229	CcSEcCtD
Epirubicin—Convulsion—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000229	CcSEcCtD
Epirubicin—Pain—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000229	CcSEcCtD
Epirubicin—Constipation—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000229	CcSEcCtD
Epirubicin—Insomnia—Losartan—type 2 diabetes mellitus	6.27e-05	0.000228	CcSEcCtD
Epirubicin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000227	CcSEcCtD
Epirubicin—Paraesthesia—Losartan—type 2 diabetes mellitus	6.22e-05	0.000226	CcSEcCtD
Epirubicin—Urticaria—Metformin—type 2 diabetes mellitus	6.2e-05	0.000225	CcSEcCtD
Epirubicin—Arthralgia—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000225	CcSEcCtD
Epirubicin—Myalgia—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000225	CcSEcCtD
Epirubicin—Chest pain—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000225	CcSEcCtD
Epirubicin—Dyspnoea—Losartan—type 2 diabetes mellitus	6.18e-05	0.000224	CcSEcCtD
Epirubicin—Anxiety—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000224	CcSEcCtD
Epirubicin—Nausea—Glyburide—type 2 diabetes mellitus	6.17e-05	0.000224	CcSEcCtD
Epirubicin—Abdominal pain—Metformin—type 2 diabetes mellitus	6.17e-05	0.000224	CcSEcCtD
Epirubicin—Dizziness—Gliclazide—type 2 diabetes mellitus	6.17e-05	0.000224	CcSEcCtD
Epirubicin—Somnolence—Losartan—type 2 diabetes mellitus	6.16e-05	0.000224	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000224	CcSEcCtD
Epirubicin—Asthenia—Valsartan—type 2 diabetes mellitus	6.15e-05	0.000223	CcSEcCtD
Epirubicin—Discomfort—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000222	CcSEcCtD
Epirubicin—Dyspepsia—Losartan—type 2 diabetes mellitus	6.1e-05	0.000222	CcSEcCtD
Epirubicin—Asthenia—Orlistat—type 2 diabetes mellitus	6.08e-05	0.000221	CcSEcCtD
Epirubicin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.07e-05	0.00022	CcSEcCtD
Epirubicin—Pruritus—Valsartan—type 2 diabetes mellitus	6.06e-05	0.00022	CcSEcCtD
Epirubicin—Dry mouth—Ramipril—type 2 diabetes mellitus	6.06e-05	0.00022	CcSEcCtD
Epirubicin—Decreased appetite—Losartan—type 2 diabetes mellitus	6.03e-05	0.000219	CcSEcCtD
Epirubicin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000219	CcSEcCtD
Epirubicin—Confusional state—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000218	CcSEcCtD
Epirubicin—Pruritus—Orlistat—type 2 diabetes mellitus	5.99e-05	0.000218	CcSEcCtD
Epirubicin—Fatigue—Losartan—type 2 diabetes mellitus	5.98e-05	0.000217	CcSEcCtD
Epirubicin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000216	CcSEcCtD
Epirubicin—Oedema—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000216	CcSEcCtD
Epirubicin—Vomiting—Gliclazide—type 2 diabetes mellitus	5.93e-05	0.000215	CcSEcCtD
Epirubicin—Constipation—Losartan—type 2 diabetes mellitus	5.93e-05	0.000215	CcSEcCtD
Epirubicin—Pain—Losartan—type 2 diabetes mellitus	5.93e-05	0.000215	CcSEcCtD
Epirubicin—Rash—Gliclazide—type 2 diabetes mellitus	5.88e-05	0.000214	CcSEcCtD
Epirubicin—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.88e-05	0.000213	CcSEcCtD
Epirubicin—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.86e-05	0.000213	CcSEcCtD
Epirubicin—Urticaria—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000212	CcSEcCtD
Epirubicin—Shock—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000212	CcSEcCtD
Epirubicin—Headache—Gliclazide—type 2 diabetes mellitus	5.84e-05	0.000212	CcSEcCtD
Epirubicin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000212	CcSEcCtD
Epirubicin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000211	CcSEcCtD
Epirubicin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000211	CcSEcCtD
Epirubicin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000211	CcSEcCtD
Epirubicin—Tachycardia—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000211	CcSEcCtD
Epirubicin—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.79e-05	0.00021	CcSEcCtD
Epirubicin—Skin disorder—Ramipril—type 2 diabetes mellitus	5.77e-05	0.00021	CcSEcCtD
Epirubicin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000209	CcSEcCtD
Epirubicin—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.71e-05	0.000207	CcSEcCtD
Epirubicin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.67e-05	0.000206	CcSEcCtD
Epirubicin—Dizziness—Valsartan—type 2 diabetes mellitus	5.67e-05	0.000206	CcSEcCtD
Epirubicin—Anorexia—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000206	CcSEcCtD
Epirubicin—Dizziness—Orlistat—type 2 diabetes mellitus	5.6e-05	0.000203	CcSEcCtD
Epirubicin—Asthenia—Metformin—type 2 diabetes mellitus	5.6e-05	0.000203	CcSEcCtD
Epirubicin—Hypotension—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000202	CcSEcCtD
Epirubicin—Nausea—Gliclazide—type 2 diabetes mellitus	5.54e-05	0.000201	CcSEcCtD
Epirubicin—Pruritus—Metformin—type 2 diabetes mellitus	5.52e-05	0.0002	CcSEcCtD
Epirubicin—Urticaria—Losartan—type 2 diabetes mellitus	5.51e-05	0.0002	CcSEcCtD
Epirubicin—Abdominal pain—Losartan—type 2 diabetes mellitus	5.48e-05	0.000199	CcSEcCtD
Epirubicin—Body temperature increased—Losartan—type 2 diabetes mellitus	5.48e-05	0.000199	CcSEcCtD
Epirubicin—Vomiting—Valsartan—type 2 diabetes mellitus	5.45e-05	0.000198	CcSEcCtD
Epirubicin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000197	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000197	CcSEcCtD
Epirubicin—Rash—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000196	CcSEcCtD
Epirubicin—Dermatitis—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000196	CcSEcCtD
Epirubicin—Vomiting—Orlistat—type 2 diabetes mellitus	5.39e-05	0.000195	CcSEcCtD
Epirubicin—Insomnia—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000195	CcSEcCtD
Epirubicin—Headache—Valsartan—type 2 diabetes mellitus	5.37e-05	0.000195	CcSEcCtD
Epirubicin—Diarrhoea—Metformin—type 2 diabetes mellitus	5.34e-05	0.000194	CcSEcCtD
Epirubicin—Rash—Orlistat—type 2 diabetes mellitus	5.34e-05	0.000194	CcSEcCtD
Epirubicin—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000194	CcSEcCtD
Epirubicin—Dermatitis—Orlistat—type 2 diabetes mellitus	5.34e-05	0.000194	CcSEcCtD
Epirubicin—Headache—Orlistat—type 2 diabetes mellitus	5.31e-05	0.000193	CcSEcCtD
Epirubicin—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000192	CcSEcCtD
Epirubicin—Asthenia—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000192	CcSEcCtD
Epirubicin—Somnolence—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000192	CcSEcCtD
Epirubicin—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.23e-05	0.00019	CcSEcCtD
Epirubicin—Pruritus—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000189	CcSEcCtD
Epirubicin—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000188	CcSEcCtD
Epirubicin—Dizziness—Metformin—type 2 diabetes mellitus	5.16e-05	0.000187	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000186	CcSEcCtD
Epirubicin—Fatigue—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000186	CcSEcCtD
Epirubicin—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.11e-05	0.000185	CcSEcCtD
Epirubicin—Nausea—Valsartan—type 2 diabetes mellitus	5.09e-05	0.000185	CcSEcCtD
Epirubicin—Constipation—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000185	CcSEcCtD
Epirubicin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000183	CcSEcCtD
Epirubicin—Nausea—Orlistat—type 2 diabetes mellitus	5.03e-05	0.000183	CcSEcCtD
Epirubicin—Asthenia—Losartan—type 2 diabetes mellitus	4.97e-05	0.000181	CcSEcCtD
Epirubicin—Vomiting—Metformin—type 2 diabetes mellitus	4.96e-05	0.00018	CcSEcCtD
Epirubicin—Rash—Metformin—type 2 diabetes mellitus	4.92e-05	0.000179	CcSEcCtD
Epirubicin—Dermatitis—Metformin—type 2 diabetes mellitus	4.92e-05	0.000178	CcSEcCtD
Epirubicin—Pruritus—Losartan—type 2 diabetes mellitus	4.9e-05	0.000178	CcSEcCtD
Epirubicin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000178	CcSEcCtD
Epirubicin—Headache—Metformin—type 2 diabetes mellitus	4.89e-05	0.000178	CcSEcCtD
Epirubicin—Dizziness—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000177	CcSEcCtD
Epirubicin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000176	CcSEcCtD
Epirubicin—Diarrhoea—Losartan—type 2 diabetes mellitus	4.74e-05	0.000172	CcSEcCtD
Epirubicin—Urticaria—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000171	CcSEcCtD
Epirubicin—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000171	CcSEcCtD
Epirubicin—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000171	CcSEcCtD
Epirubicin—Vomiting—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.00017	CcSEcCtD
Epirubicin—Rash—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000169	CcSEcCtD
Epirubicin—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000168	CcSEcCtD
Epirubicin—Nausea—Metformin—type 2 diabetes mellitus	4.64e-05	0.000168	CcSEcCtD
Epirubicin—Headache—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.000168	CcSEcCtD
Epirubicin—Dizziness—Losartan—type 2 diabetes mellitus	4.58e-05	0.000166	CcSEcCtD
Epirubicin—Vomiting—Losartan—type 2 diabetes mellitus	4.41e-05	0.00016	CcSEcCtD
Epirubicin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000159	CcSEcCtD
Epirubicin—Nausea—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000159	CcSEcCtD
Epirubicin—Rash—Losartan—type 2 diabetes mellitus	4.37e-05	0.000159	CcSEcCtD
Epirubicin—Dermatitis—Losartan—type 2 diabetes mellitus	4.37e-05	0.000159	CcSEcCtD
Epirubicin—Headache—Losartan—type 2 diabetes mellitus	4.34e-05	0.000158	CcSEcCtD
Epirubicin—Asthenia—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000155	CcSEcCtD
Epirubicin—Pruritus—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000153	CcSEcCtD
Epirubicin—Nausea—Losartan—type 2 diabetes mellitus	4.12e-05	0.000149	CcSEcCtD
Epirubicin—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000148	CcSEcCtD
Epirubicin—Dizziness—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000143	CcSEcCtD
Epirubicin—Vomiting—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000137	CcSEcCtD
Epirubicin—Rash—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000136	CcSEcCtD
Epirubicin—Dermatitis—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000136	CcSEcCtD
Epirubicin—Headache—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000135	CcSEcCtD
Epirubicin—Nausea—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000128	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.07e-05	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.07e-05	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.07e-05	0.00014	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC9A1—type 2 diabetes mellitus	2.06e-05	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.04e-05	0.000138	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.04e-05	0.000138	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.03e-05	0.000137	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSMD6—type 2 diabetes mellitus	2.02e-05	0.000137	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SREBF1—type 2 diabetes mellitus	2.02e-05	0.000137	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SNAP25—type 2 diabetes mellitus	2.02e-05	0.000137	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.01e-05	0.000136	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.99e-05	0.000135	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CTGF—type 2 diabetes mellitus	1.99e-05	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SREBF1—type 2 diabetes mellitus	1.99e-05	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSMD6—type 2 diabetes mellitus	1.99e-05	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SNAP25—type 2 diabetes mellitus	1.99e-05	0.000134	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GLP1R—type 2 diabetes mellitus	1.98e-05	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.97e-05	0.000133	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMGCR—type 2 diabetes mellitus	1.97e-05	0.000133	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CTGF—type 2 diabetes mellitus	1.95e-05	0.000132	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HMGA1—type 2 diabetes mellitus	1.93e-05	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMGCR—type 2 diabetes mellitus	1.93e-05	0.00013	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ADRA2A—type 2 diabetes mellitus	1.93e-05	0.00013	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.91e-05	0.000129	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.9e-05	0.000129	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSMD6—type 2 diabetes mellitus	1.89e-05	0.000128	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SNAP25—type 2 diabetes mellitus	1.89e-05	0.000128	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADRA2A—type 2 diabetes mellitus	1.89e-05	0.000128	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.87e-05	0.000126	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.87e-05	0.000126	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.85e-05	0.000125	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2E1—type 2 diabetes mellitus	1.85e-05	0.000125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.85e-05	0.000125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.84e-05	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CYBA—type 2 diabetes mellitus	1.83e-05	0.000124	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1A2—type 2 diabetes mellitus	1.83e-05	0.000124	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC2A1—type 2 diabetes mellitus	1.83e-05	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INSR—type 2 diabetes mellitus	1.83e-05	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP2E1—type 2 diabetes mellitus	1.82e-05	0.000123	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CPT1A—type 2 diabetes mellitus	1.82e-05	0.000123	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTR—type 2 diabetes mellitus	1.82e-05	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.8e-05	0.000121	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1A2—type 2 diabetes mellitus	1.8e-05	0.000121	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC2A1—type 2 diabetes mellitus	1.8e-05	0.000121	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.79e-05	0.000121	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.79e-05	0.000121	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP3A4—type 2 diabetes mellitus	1.79e-05	0.000121	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NAMPT—type 2 diabetes mellitus	1.78e-05	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CALCA—type 2 diabetes mellitus	1.77e-05	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.77e-05	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LIPC—type 2 diabetes mellitus	1.77e-05	0.000119	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GCK—type 2 diabetes mellitus	1.77e-05	0.000119	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HBA1—type 2 diabetes mellitus	1.77e-05	0.000119	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.76e-05	0.000119	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.76e-05	0.000119	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC2A4—type 2 diabetes mellitus	1.76e-05	0.000119	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GCG—type 2 diabetes mellitus	1.76e-05	0.000119	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP3A4—type 2 diabetes mellitus	1.75e-05	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.74e-05	0.000118	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.73e-05	0.000117	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—C3—type 2 diabetes mellitus	1.72e-05	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GCG—type 2 diabetes mellitus	1.72e-05	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC2A4—type 2 diabetes mellitus	1.72e-05	0.000116	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC2A1—type 2 diabetes mellitus	1.71e-05	0.000116	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.71e-05	0.000116	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CETP—type 2 diabetes mellitus	1.71e-05	0.000115	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS1—type 2 diabetes mellitus	1.69e-05	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TCF7L2—type 2 diabetes mellitus	1.67e-05	0.000113	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.66e-05	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.66e-05	0.000112	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC2A4—type 2 diabetes mellitus	1.64e-05	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.64e-05	0.00011	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.62e-05	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.61e-05	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.61e-05	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.59e-05	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SNAP25—type 2 diabetes mellitus	1.59e-05	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SREBF1—type 2 diabetes mellitus	1.59e-05	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSMD6—type 2 diabetes mellitus	1.59e-05	0.000107	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.58e-05	0.000107	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.57e-05	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.57e-05	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CTGF—type 2 diabetes mellitus	1.56e-05	0.000105	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.55e-05	0.000105	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SRC—type 2 diabetes mellitus	1.55e-05	0.000105	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMGCR—type 2 diabetes mellitus	1.54e-05	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.52e-05	0.000103	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNB3—type 2 diabetes mellitus	1.51e-05	0.000102	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.51e-05	0.000102	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.51e-05	0.000102	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.51e-05	0.000102	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.51e-05	0.000102	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—type 2 diabetes mellitus	1.51e-05	0.000102	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—type 2 diabetes mellitus	1.51e-05	0.000102	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAT—type 2 diabetes mellitus	1.49e-05	0.0001	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNB3—type 2 diabetes mellitus	1.48e-05	0.0001	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.48e-05	0.0001	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—type 2 diabetes mellitus	1.48e-05	9.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.46e-05	9.89e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAT—type 2 diabetes mellitus	1.46e-05	9.84e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.45e-05	9.8e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOB—type 2 diabetes mellitus	1.44e-05	9.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.44e-05	9.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.44e-05	9.72e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.43e-05	9.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.43e-05	9.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFBR2—type 2 diabetes mellitus	1.43e-05	9.65e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.42e-05	9.57e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOB—type 2 diabetes mellitus	1.41e-05	9.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.41e-05	9.54e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—type 2 diabetes mellitus	1.4e-05	9.48e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.4e-05	9.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.39e-05	9.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN2B—type 2 diabetes mellitus	1.38e-05	9.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—type 2 diabetes mellitus	1.38e-05	9.35e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LPL—type 2 diabetes mellitus	1.38e-05	9.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—type 2 diabetes mellitus	1.38e-05	9.3e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GCG—type 2 diabetes mellitus	1.38e-05	9.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.38e-05	9.29e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LPL—type 2 diabetes mellitus	1.35e-05	9.12e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOB—type 2 diabetes mellitus	1.35e-05	9.12e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ADCY5—type 2 diabetes mellitus	1.35e-05	9.11e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.35e-05	9.1e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX1—type 2 diabetes mellitus	1.34e-05	9.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.32e-05	8.94e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADCY5—type 2 diabetes mellitus	1.32e-05	8.93e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX1—type 2 diabetes mellitus	1.32e-05	8.9e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CD36—type 2 diabetes mellitus	1.31e-05	8.84e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPP2CA—type 2 diabetes mellitus	1.29e-05	8.73e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LPL—type 2 diabetes mellitus	1.29e-05	8.71e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CD36—type 2 diabetes mellitus	1.28e-05	8.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPP2CA—type 2 diabetes mellitus	1.27e-05	8.56e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ADCY5—type 2 diabetes mellitus	1.26e-05	8.52e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.25e-05	8.46e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.24e-05	8.38e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—type 2 diabetes mellitus	1.24e-05	8.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.22e-05	8.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.22e-05	8.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.22e-05	8.23e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARA—type 2 diabetes mellitus	1.22e-05	8.22e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—type 2 diabetes mellitus	1.22e-05	8.22e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.21e-05	8.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PPP2CA—type 2 diabetes mellitus	1.21e-05	8.17e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.2e-05	8.11e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARA—type 2 diabetes mellitus	1.19e-05	8.06e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—type 2 diabetes mellitus	1.19e-05	8.02e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNB3—type 2 diabetes mellitus	1.19e-05	8.01e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.19e-05	8.01e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.18e-05	7.99e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—type 2 diabetes mellitus	1.18e-05	7.97e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AGT—type 2 diabetes mellitus	1.18e-05	7.96e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.18e-05	7.96e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAT—type 2 diabetes mellitus	1.16e-05	7.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.16e-05	7.86e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—type 2 diabetes mellitus	1.16e-05	7.84e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CALM1—type 2 diabetes mellitus	1.16e-05	7.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AGT—type 2 diabetes mellitus	1.16e-05	7.81e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOE—type 2 diabetes mellitus	1.15e-05	7.8e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—type 2 diabetes mellitus	1.15e-05	7.78e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOA1—type 2 diabetes mellitus	1.14e-05	7.71e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CALM1—type 2 diabetes mellitus	1.14e-05	7.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOE—type 2 diabetes mellitus	1.13e-05	7.65e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOB—type 2 diabetes mellitus	1.13e-05	7.64e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LPL—type 2 diabetes mellitus	1.13e-05	7.63e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOA1—type 2 diabetes mellitus	1.12e-05	7.56e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIF1A—type 2 diabetes mellitus	1.11e-05	7.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.11e-05	7.47e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS2—type 2 diabetes mellitus	1.1e-05	7.46e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—type 2 diabetes mellitus	1.1e-05	7.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CALM1—type 2 diabetes mellitus	1.08e-05	7.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOE—type 2 diabetes mellitus	1.08e-05	7.3e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LPL—type 2 diabetes mellitus	1.08e-05	7.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOA1—type 2 diabetes mellitus	1.07e-05	7.21e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.06e-05	7.16e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADCY5—type 2 diabetes mellitus	1.06e-05	7.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX1—type 2 diabetes mellitus	1.05e-05	7.11e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.04e-05	7.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CD36—type 2 diabetes mellitus	1.03e-05	6.93e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C3—type 2 diabetes mellitus	1.02e-05	6.87e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.01e-05	6.84e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—type 2 diabetes mellitus	1.01e-05	6.8e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—type 2 diabetes mellitus	1.01e-05	6.79e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—INS—type 2 diabetes mellitus	9.86e-06	6.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—type 2 diabetes mellitus	9.86e-06	6.66e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	9.72e-06	6.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.7e-06	6.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.68e-06	6.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—INS—type 2 diabetes mellitus	9.67e-06	6.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGT—type 2 diabetes mellitus	9.66e-06	6.53e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS1—type 2 diabetes mellitus	9.64e-06	6.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—type 2 diabetes mellitus	9.62e-06	6.5e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	9.53e-06	6.44e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.5e-06	6.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—type 2 diabetes mellitus	9.47e-06	6.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOE—type 2 diabetes mellitus	9.47e-06	6.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.36e-06	6.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	9.23e-06	6.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—INS—type 2 diabetes mellitus	9.23e-06	6.23e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	9.08e-06	6.13e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	9.05e-06	6.11e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—type 2 diabetes mellitus	9.04e-06	6.11e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	8.94e-06	6.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.93e-06	6.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT2—type 2 diabetes mellitus	8.92e-06	6.03e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—type 2 diabetes mellitus	8.87e-06	5.99e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3R1—type 2 diabetes mellitus	8.65e-06	5.84e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—type 2 diabetes mellitus	8.65e-06	5.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—type 2 diabetes mellitus	8.48e-06	5.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3R1—type 2 diabetes mellitus	8.48e-06	5.73e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	8.48e-06	5.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.45e-06	5.71e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	8.09e-06	5.47e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—type 2 diabetes mellitus	8.09e-06	5.47e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INS—type 2 diabetes mellitus	8.09e-06	5.46e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.96e-06	5.38e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—type 2 diabetes mellitus	7.91e-06	5.34e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	7.88e-06	5.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.82e-06	5.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.82e-06	5.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.79e-06	5.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—type 2 diabetes mellitus	7.76e-06	5.24e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—INS—type 2 diabetes mellitus	7.73e-06	5.22e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.43e-06	5.02e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	7.4e-06	5e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.09e-06	4.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.09e-06	4.79e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	7.09e-06	4.79e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.78e-06	4.58e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	6.78e-06	4.58e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RELA—type 2 diabetes mellitus	6.68e-06	4.51e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	6.2e-06	4.19e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.02e-06	4.07e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SRC—type 2 diabetes mellitus	5.99e-06	4.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.98e-06	4.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.69e-06	3.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.63e-06	3.8e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.52e-06	3.73e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	5.35e-06	3.61e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—type 2 diabetes mellitus	5.25e-06	3.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.25e-06	3.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.11e-06	3.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.69e-06	3.17e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.6e-06	3.11e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—type 2 diabetes mellitus	4.03e-06	2.72e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	3.98e-06	2.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—type 2 diabetes mellitus	3.9e-06	2.63e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—type 2 diabetes mellitus	3.72e-06	2.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.53e-06	2.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.26e-06	2.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	3.12e-06	2.1e-05	CbGpPWpGaD
